Apotex alleged that specific US courtroom judgments and FDA decisions discriminated from it, denied it minimum typical of cure and expropriated its investment in pravastatin. Damages sought: US£8 million.The Trader alleged that actions taken by Mexican tax authority, which were being intended to revoke investor's Beforehand granted legal rights, e